NDC 70842-102
Baxdela 300 mg per 10.5 mL injection, powder, lyophilized, for solution
On the label: Melinta Therapeutics, LLC.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Bostal LLC | Edison, NJ, United States | Makes it and tests it | Problems found, fixed voluntarilyDec 4, 2024 · 7 inspections |
| ScinoPharm Taiwan, Ltd. | Tainan, Taiwan | Makes the active ingredient, tests it and packages it | Serious problems, FDA actionJun 23, 2026 · 7 inspections, 1 with FDA action |
| Pharma Packaging Solutions, LLC | Clinton, TN, United States | Packages it and labels it | No problems foundJun 28, 2023 · 4 inspections |
| SGS North America Inc. | Fairfield, NJ, United States | Tests it | Problems found, fixed voluntarilyJun 9, 2026 · 8 inspections |
Product details
- Generic drug
- Delafloxacin: every company that makes it
- Form
- injection, powder, lyophilized, for solution, intravenous
- Strength
- 300 mg per 10.5 mL
- Approval
- NDA NDA208611
- On the market since
- Jun 19, 2017
- Package NDCs
70842-102-0170842-102-03- Official label
- DailyMed (National Library of Medicine), updated Aug 1, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?